BRUSSELS: As the European Union is reopening borders to non-EU tourists especially those who have been fully vaccinated against Covid-19, travelers inoculated with the Indian-made AstraZeneca vaccine, or Covishield, could face problems when entering the bloc, the European Commission suggested on Friday (Saturday in Manila).

While the AstraZeneca vaccine produced in Europe, branded Vaxzevira, has been green lighted by the European Medicines Agency (EMA), the Indian version Covishield has not even requested for the market authorization, according to Stefan De Keersmaecker, the commission's spokesman for health issues.